[1] BIEDERMANN D, VAV?ÍKOVÁ E, CVAK L, et al. Chemistry of silybin[J]. Nat Prod Rep, 2014, 31(9):1138-1157
[2] WANG X, LIN F, XU W, et al. Silybin B exerts protective effect on cisplatin-induced neurotoxicity by alleviating DNA damage and apoptosis[J]. Journal of Ethnopharmacology, 2022, doi:10.1016/j.jep.2021.114938
[3] K?EN V, GA?ÁK R, KATE?INA P. Chemoenzymatic preparative separation of silybins A and B[J]. Journal of Molecular Catalysis B:Enzymatic, 2009, 61(3/4):247-251
[4] DI COSTANZO A, ANGELICO R. Formulation strategies for enhancing the bioavailability of silymarin:The state of the art[J]. Molecules (Basel, Switzerland), 2019, doi:10.3390/molecules2411255
[5] ZHANG Z, LI D, LUO C, et al. Cocrystals of natural products:Improving the dissolution performance of flavonoids using betaine[J]. Crystal Growth & Design, 2019, 19(7):3851-3859
[6] NUGRAHANI I, UTAMI D, AYUNINGTYAS L, et al. New preparation method using microwave, kinetics, in vitro dissolution-diffusion, and anti-inflammatory study of diclofenac-proline co-crystal[J]. ChemistrySelect, 2019, 4(45):13396-13403
[7] RAJBONGSHI T, SARMAH K K, SARKAR A, et al. Preparation of pyrazinamide eutectics versus cocrystals based on supramolecular synthon variations[J]. Crystal Growth & Design, 2018, 18(11):6640-6651
[8] PARK B, YOON W, YUN J, et al. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility[J]. International Journal of Pharmaceutics, 2019, 557:26-35
[9] PATEL J R, CARLTON R A, NEEDHAM T E, et al. Preparation, structural analysis, and properties of tenoxicam cocrystals[J]. International Journal of Pharmaceutics, 2012, 436(1/2):685-706
[10] WANG Y, XUE J, WANG Q, et al. Structural investigation of a 2:1 co-crystal between diflunisal and isonicotinamide based on terahertz and Raman spectroscopy[J]. Spectrochimica Acta Part A:Molecular and Biomolecular Spectroscopy, 2019, 216:98-104
[11] ZHANG Z, CAI Q, XUE J, et al. Co-crystal formation of antibiotic nitrofurantoin drug and melamine co-former based on a vibrational spectroscopic study[J]. Pharmaceutics, 2019, doi:10.3390/pharmaceutics11020056
[12] K?EN V. Chirality matters:Biological activity of optically pure silybin and its congeners[J]. International Journal of Molecular Sciences, 2021, doi:10.3390/ijms22157885
|
2023, Vol. 40 
